Welcome to the first part of our Cancer Cachexia ASCO 2025 Highlights. Cancer cachexia is a progressive muscle-wasting syndrome that significantly diminishes the quality of life for many patients with cancer. For this episode we are joined by Associate Professor Richard Dunne who will be sharing his highlights from ASCO 2025, specifically addressing the latest research concerning cancer cachexia, its progression, methods for clinically scoring and staging the condition, including novel approaches and factors associated with its incidents.

This discussion was originally broadcast as a Conference Highlights Video, published as part of the American Cancer Society - Cancer Cachexia Knowledge Hub educational program. To view the original video please visit https://cancercachexia.knowledgehub.wiley.com/conference-coverage/asco-2025-highlights/. The Knowledge Hub also contains additional educational materials on cancer cachexia, including two ACCME accredited webinar broadcasts, conference highlights from AACR 2025, ASCO 2025, ASCO GI 2026, ESMO 2025, SCWD 2024 and 2025 as well as additional resources such as research article collections and downloadable infographics.

The Cancer Cachexia Knowledge Hub program is supported by an educational grant from Pfizer.

Speaker – Dr Richard Dunne. Associate Professor of Medicine & Section Leader, GI Oncology, Wilmot Cancer Institute and The University of Rochester Medical Center. Full speaker biography - https://cancercachexia.knowledgehub.wiley.com/faculty/

For more medical education from Wiley, please visit https://focus.wiley.com/